NITSCHE DIETRICH has a total of 15 patent applications. Its first patent ever was published in 1988. It filed its patents most often in Germany, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and environmental technology are MONKAM NITCHEU GUY FAUSTIN, HSRX GROUP LLC and MENLO THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Germany | 5 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | Hungary | 1 | |
#5 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Nitsche Dietrich | 10 |
#2 | Nitsche Dietrich Dr | 5 |
Publication | Filing date | Title |
---|---|---|
US5240909A | Use of lactoferrin for treatment of toxic effects of endotoxins | |
DE4109254A1 | USE OF APOTRANSFERRIN, WHICH GIVEN TWO-VALUE CATIONS, TO CONTROL THE TOXIC EFFECT OF ENDOTOXIN | |
DE4008033A1 | USE OF LACTOFERRINE TO CONTROL THE TOXIC EFFECT OF ENDOTOXIN | |
DE3910011A1 | USE OF INTERLEUKIN-2 IN EXTENDED BACTERIAL INFECTIONS | |
DE3844667A1 | Use of transferrin for controlling the toxic effect of endotoxin in endotoxinaemia | |
DE3842143A1 | USE OF TRANSFERRIN FOR ENDOTOXIN NEUTRALIZATION |